Formulation

Feb 09, 2018
By Pharmaceutical Technology Editors
The acquisition strengthens an already existing collaboration between the companies to advance clinical development of therapies across multiple drug categories.
Feb 02, 2018
Pharmaceutical Technology
Mark Egerton, PhD, chief executive officer of Quotient Sciences, shares insights on a new approach to accelerate drug development, which integrates formulation development, real-time adaptive GMP manufacturing, and clinical research within a single platform.
Jan 02, 2018
Pharmaceutical Technology
The authors offer recommendations for permissible daily exposures and concentration limits of elemental impurities for dermal drug products.
Jan 02, 2018
Pharmaceutical Technology
Abuse-deterrent opioid formulations generally fall into two categories: the first is based on a physiochemical abuse-deterrent approach and the second combines the opioid with an antagonist.
Dec 06, 2017
Equipment and Processing Report
Orbis Biosciences’ Optimµm Platform delivers microparticulate dosage forms with controlled-release and taste-masked properties in a single manufacturing step.
Dec 02, 2017
Pharmaceutical Technology
Amid business and regulatory uncertainty, bio/pharma experts reveal opinions on salary, recognition, and training.
Dec 02, 2017
Pharmaceutical Technology
Is pharma up to the task of developing knowledgeable, motivated employees?
Dec 02, 2017
Pharmaceutical Technology
Attracting and retaining qualified bio/pharma experts demands a mix of recognition, rewards, and opportunities.
Dec 02, 2017
Pharmaceutical Technology
Modified-release lipid-based formulations in softgel capsules can address physiochemical and pharmacokinetic challenges posed by drug compounds.
Dec 02, 2017
Pharmaceutical Technology
Softgel capsules are a popular dosage form among patients but they also provide a number of manufacturing benefits over liquid-filled hardgel capsules.
native1_300x100
lorem ipsum